Quotient (QTNT) – StreetInsider.com Reports
-
Quotient (QTNT) to Voluntary Delist from the Nasdaq Global Market
-
Quotient (QTNT) Halted, News Pending
-
Quotient (QTNT) PT Lowered to $1 at Goldman Sachs
-
Quotient (QTNT) Announces 1:40 Reverse Stock Split is Effective Today, November 2nd
-
Quotient (QTNT) Announces 1:40 Reverse Stock Split
-
Quotient (QTNT) Announces 8.5M Share Offering by Selling Stockholders
-
Quotient (QTNT) Misses Q2 EPS by 19c
-
Quotient (QTNT) and InfYnity Biomarkers Announce Partnership to Expand MosaiQ Infectious Disease Menu
-
Quotient (QTNT) PT Lowered to $3 at Cowen
-
Quotient (QTNT) PT Lowered to $1.50 at BTIG
-
Quotient Limited (QTNT) Prices 66.67M Share Offering at $0.30/sh
-
Quotient (QTNT) Reports Q4 Revenue of $9.8M, Loss of $26.87M, Provides Business Update
-
Quotient (QTNT) Announces Proposed $20M Underwritten Offering
-
Quotient (QTNT) and Theradiag Partner to Advance Autoimmune Disease Diagnostics
-
Quotient (QTNT) Opens Dubai Office
-
Quotient (QTNT) Appoints Thomas Aebischer to its Board
-
Quotient (QTNT) Announces Receipt of CE Mark for the Extended Immunohematology Microarray
-
Quotient (QTNT) Issues MosaiQ Regulatory & Commercial Update
-
Quotient (QTNT) PT Lowered to $11 at BTIG
-
Quotient (QTNT) Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress
-
Quotient (QTNT) Files For Up to 2.78M Share Offering by Selling Stockholders
-
Quotient (QTNT) Delays Q2 Release, Provides Business Update
-
Quotient (QTNT) Announces Appointment of Ali Kiboro as Chief Financial Officer
-
Quotient (QTNT) Announces Appointment of New Chief Scientific & Medical Officer
-
Quotient (QTNT) Provides Update on CE Marking Progress of the MosaiQ Expanded Immunohematology Microarray
-
Quotient (QTNT) PT Lowered to $4.50 at Goldman Sachs, Following Earnings
-
Quotient (QTNT) on Watch on Chatter
-
Quotient (QTNT) Files Proposed 18.5M Share Offering
-
Quotient (QTNT) Announces Departure of Chief Financial Officer, Peter Buhler
-
UPDATE: Goldman Sachs Starts Quotient (QTNT) at Neutral
-
Quotient (QTNT) Announces Manuel Mendez as Chief Executive Officer
-
Pre-Open Stock Movers 02/01: (VIE) (THCB) (CDE) Higher; (QTNT) (NNOX) (GME) Lower (more...)
-
Quotient (QTNT) Announces Departure of COO
-
Quotient (QTNT) Provides Status Update on the Initial SDS Microarray and MosaiQ Instrument for the US Market
-
Quotient (QTNT) Announces Receipt of U.S. FDA Emergency Use Authorization for MosaiQ COVID-19 Antibody test
-
Quotient (QTNT) Prices 17.647M Upsized Common Offering at $4.25/Sh
-
Pre-Open Movers 09/10: (VRTU) (RH) (NAV) Higher; (STSA) (PRPL) (NKLA) Lower (more...)
-
After-Hours Movers 09/09: (RMTI) (RH) (SLQT) Higher; (PRPL) (GME) (BIGC) Lower (more...)
-
Quotient (QTNT) Announces Proposed $60M Common Share Offering
-
Quotient (QTNT) and Ortho Clinical Diagnostics Settle Arbitration and Sign Binding LOI Covering Patient Transfusion Diagnostics
-
Quotient (QTNT) Announces 'Impressive' Results from Independent SARS-CoV-2 Antibody Detection Study Conducted in Spain
-
UPDATE: Quotient (QTNT) Tops Q4 EPS by 3c, Revenues Beat; Offers FY21 'Alba' Product Sales Guidance Above Revs. Views, Provides 1Q 'Alba' Product Sales Outlook
-
Cowen Positive on Quotient (QTNT) on hVIVO COVID-19 Commercial Update
-
Quotient (QTNT) Announces CE Mark for its SARS-CoV-2 (COVID-19) Antibody Microarray
-
Pre-Open Movers 04/28: (IBIO) (RTIX) (FFIV) Higher; (NBES) (HLIT) (GAIA) Lower (more...)
-
After-Hours Movers 04/27: (RTIX) (IBIO) (QTNT) Higher; (GAIA) (NBSE) (HLIT) Lower (more...)
-
Quotient (QTNT) Announces SARS-CoV-2 (COVID-19) Antibody Test Final Performance Data
-
Pre-Open Stock Movers 04/22: (IMUX) (SNAP) (CMG) Higher; (VBIV) (IBKR) (BIIB) Lower (more...)
-
After-Hours Stock Movers 04/21: (IMUX) (SNAP) (USNA) Higher; (VBIV) (IBKR) (UAL) Lower (more...)
-
Quotient (QTNT) Announces SARS-CoV-2 Antibody Test Has 100% Sensitivity, 95% Specificity
Back to QTNT Stock Lookup